Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-038731

Chief Legal Officer sold 5,833 shares at $35.04 ($204,410)

  • Chief Legal Officer acquired 5,833 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2024-03-27 Option exercise 10b5-1 +4,342 $25.98 $112,805 6,079 D
Bizily Scott Chief Legal Officer 2024-03-27 Option exercise 10b5-1 +1,491 $25.98 $38,736 7,570 D
Bizily Scott Chief Legal Officer 2024-03-27 Sale 10b5-1 −5,833 $35.04 $204,410 1,737 D
Derivatives
Bizily Scott Chief Legal Officer 2024-03-27 Option exercise · Stock Option (Right To Buy) 10b5-1 −4,342 55,658 D
Bizily Scott Chief Legal Officer 2024-03-27 Option exercise · Stock Option (Right To Buy) 10b5-1 −1,491 54,167 D
Open-market sales · 5,833 sh · avg $35.04 · $204,410
Loading xslF345X05/ownership.xml…